Opticlude is a brand of orthoptic eye patches manufactured by 3M and its healthcare spinoff, Solventum. They are specialized medical devices used primarily in vision-occlusive therapy to treat common childhood eye conditions.

Core Product Purpose

Opticlude patches are designed for the treatment of:
– Amblyopia (commonly known as “lazy eye”).
– Strabismus (crossed eyes or squints).

The patch is worn over the “preferred” (stronger) eye, which forces the weaker eye to function and strengthens its visual development.

Key Product Features

Adhesive Technology:
They utilize hypoallergenic 3M™ Micropore™ tape or silicone adhesive technology, designed to be gentle on sensitive skin while remaining secure during the occlusion period.

Comfort and Breathability:
The backing is made of a breathable, microporous material that allows the skin to function normally. The patches are thin enough to be worn under corrective glasses.

Non-Stick Pad:
Each patch features a central, non-adherent absorbent pad that protects the eye and prevents lacrimal (tear) secretions from sticking to the skin.

Ergonomic Design:
The patches are contoured and notched at the nose bridge to ensure a proper fit without requiring cutting or folding.

Targeted Demographics and Varieties

Pediatric Focus:
Because treatment often begins in childhood, many Opticlude products feature fun designs, such as Disney and Marvel characters (e.g., Avengers, Spider-Man, Frozen), to encourage children to comply with therapy.

Size Options:
They are available in various sizes to accommodate different ages and face shapes:

Mini:
Typically for children up to 2 years old.

Midi:
For children aged 2 to 4 years.

Maxi/Regular:
For older children and adults.

Nexcare™ Branding:
In some regions, Opticlude is marketed under the Nexcare™ brand, which is 3M’s consumer-facing healthcare line.